Joint Fellowship Training Program Fellows Jee Chung, Ph.D. Phone:   301-451-9758 E-Mail:   Jee.Chung@fda.hhs.gov Professional Background Dr. Chung received her Ph.D. in Cellular and Molecular Pharmacology from Rutgers University/UMDNJ in New Jersey and did post-doctoral training in the department of Biochemistry at Weill Medical College of Cornell University. She began the NCI-FDA Oncology Product Research/Review Fellowship program in October 2005. Research Interests Dr. Chung's research background incorporates two interdisciplinary fields of Pharmacology and Protein Biochemistry/Structural Biology. As a graduate student, she focused on elucidating the anti-tumorigenic mechanisms of green and black tea polyphenols to better understand the chemopreventive properties of tea. This led her to pursue post-doctoral training in protein crystallography to determine structural information of downstream signaling mediators of tumor necrosis factor-alpha signal transduction pathway. Dr. Chung's interests in mechanisms of action of potential cancer therapeutic agents inspired her to explore the regulatory aspect of cancer drug development. As an NCI-FDA Fellow, she is currently being trained to review protein drug applications for cancer therapy at the FDA. In addition to regulatory work, she is interested in examining the mechanism of iron chelator induced cytostasis of human breast cancer cells. Fellowship Experiences "The NCI-FDA Fellowship has provided me an excellent learning experience that merges both basic cancer research and FDA regulations on drug products. Situated on the NIH campus, I have benefited from the many seminars and courses that are offered year-round. In addition, FDA offers courses to train scientists on why and how to conduct product review. I found the "Introduction to Drug Law and Regulations" as well as "FDA Review of Biologics from A to Z" to be very applicable to my current review work in FDA's Division of Therapeutic Proteins. The review of biologics has introduced a wider perspective of the pharmaceutical/biotech industry from just understanding drug discovery to drug manufacture, in which the safety and efficacy through quality of the product has very direct consequences." Career Goals "I look forward to the challenges of a career in regulatory affairs where I welcome the opportunity to draw upon different scientific disciplines to evaluate and facilitate the emergence of new therapies to cancer patients expeditiously."

Home   |   Privacy Notice   |   Accessibility